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Abstract: 
 
Expressed human milk can be donated or sold through a variety of channels, including human 
milk banks, corporations or individuals, or peer‐to‐peer milk sharing. There is a paucity of 
research regarding the nutrient and bioactive profiles of expressed human milk exchanged 
through commerce‐free scenarios, including peer‐to‐peer milk sharing. The study objective was 
to evaluate the macronutrient, antimicrobial protein, and bacteria composition in expressed 
human milk acquired via commerce‐free arrangements. Expressed human milk samples were 
collected from the following commerce‐free scenarios: milk expressed for a mother's or parent's 
own infant (MOM; N = 30); unpasteurized milk donated to a non‐profit milk bank 
(BANKED; N = 30); milk expressed for peer‐to‐peer milk sharing (SHARED; N = 31); and 
health professional‐facilitated milk sharing where donors are serologically screened and milk is 
dispensed raw (SCREENED; N = 30). Analyses were conducted for total protein, lactose, percent 
fat and water, lysozyme activity, immunoglobulin A (IgA) activity, total aerobic bacteria, 
coliform, and Staphylococcus aureus. No bacterial growth was observed in 52/121 samples, and 
15/121 had growth greater than 5.0 log colony‐forming units/mL. There was no evidence of 
differences by groups (p > .05) in lactose, fat, water, lysozyme activity, sIgA activity, aerobic 
bacteria, coliforms, and S. aureus. Mean protein values (95% confidence interval) were 1.5 g/dL 
(1.4, 1.6) for BANKED, 1.4 g/dL (1.3, 1.5) for MOM, 1.6 g/dL (1.5, 1.7) for SCREENED, and 
1.5 g/dL (1.4, 1.6) for SHARED, which was not significantly different (p = .081). This research 
contributes to growing literature on the risks and benefits of uncompensated, peer‐to‐peer milk 
sharing. 
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Article: 
 
1 INTRODUCTION 
 
Increasingly in the United States, expressed human milk is a valued resource that is donated, 
shared, or sold through a variety of channels, including non‐profit milk banks (e.g., Human Milk 
Banking Association of North America [HMBANA]), selling to a corporation or an individual 
(e.g., Medolac Laboratories, Prolacta Bioscience), and sharing with a peer (Akre, Gribble, & 
Minchin, 2011; Cassidy, 2012; Gribble, 2014; Keim et al., 2014; Palmquist & Doehler, 2014; 
Perrin, Goodell, Allen, & Fogleman, 2014; Reyes‐Foster, Carter, & Hinojosa, 2015). Human 
milk sharing refers to the unpaid donation of a mother's or parent's own expressed milk to a 
family who will use the milk to provide nourishment to their infant(s) and/or young child(ren) 
(Palmquist & Doehler, 2014; Palmquist & Doehler, 2016). Human milk donated to and 
dispensed by HMBANA and human milk that is purchased for use in commercial products are 
subject to extensive screening as are the individuals who have donated or sold the milk (Prolacta 
Bioscience, 2017; HMBANA, 2015). The American Academy of Paediatrics (AAP) has 
cautioned against milk sharing for the high‐risk infant (AAP, 2017), and the U.S. Food and Drug 
Administration (FDA) has warned against the sharing or purchasing of human milk directly 
between individuals, due to the risk of pathogen transmission and exposures to potentially 
harmful substances (USFDA, 2015b). Research suggests that human milk sharing should be 
distinguished from purchasing because it does not involve a monetary exchange (Gribble & 
Hausman, 2012; Palmquist & Doehler, 2016; Rasmussen, Felice, O'Sullivan, Garner, & 
Geraghty, 2017; Reyes‐Foster et al., 2015). 
 
Despite warnings from the AAP and FDA, there is growing evidence of active milk sharing 
communities in the United States, often facilitated by the Internet (Palmquist & Doehler, 2014; 
Perrin et al., 2014; Reyes‐Foster et al., 2015). Recent research suggests that lactating women in 
the United States are generally aware of the concept of peer milk sharing and many are receptive 
to it (Keim et al., 2014; O'Sullivan, Geraghty, & Rasmussen, 2016; O'Sullivan, Geraghty, & 
Rasmussen, 2017; Perrin et al., 2016). Additionally, there are case reports of undisclosed use of 
peer‐shared milk in paediatric inpatient settings (Barbas, Sussman‐Karten, Kamin, & 
Huh, 2017). Collectively, these reports suggest an imperative for health care providers to be able 
to offer evidence‐based guidance about peer‐to‐peer milk sharing that enables families to make 
informed decisions. 
 
There is a dearth of studies that have investigated the relative risks, benefits, and costs of milk 
sharing by examining human milk samples, and only the Australian College of Midwives 
(Australian College of Midwives, 2014) and the American Academy of Nursing (American 
Academy of Nursing, 2016) offer evidence‐based position statements. Analysis of the U.S. 
media suggests differing language used to discuss human milk based on the mode of exchange, 
with human milk received through formal milk banks framed as “liquid gold” while human milk 
exchanged informally via peers framed as “fool's gold,” though limited data exist to support this 
dichotomous discourse on human milk quality (Carter & Reyes‐Foster, 2016). 
 
The quality of expressed human milk can be evaluated based on multiple criteria, including the 
level of potential pathogens and contaminants (the risks) and the level of nutrients and bioactive 
substances (the benefits). These factors have been studied in human milk donated to HMBANA 
banks (Cohen, Xiong, & Sakamoto, 2010; Landers & Updegrove, 2010; Perrin, Fogleman, 
Newburg, & Allen, 2017) and in some commercial human milk products (Bloom, 2016; Wojcik, 
Rechtman, Lee, Montoya, & Medo, 2009). Globally, there are no agreed upon standards for 
acceptable bacteria levels in raw human milk in the context of donor milk banking 
(PATH, 2013). Recent research into pathogens and contaminants in human milk purchased 
anonymously on the Internet and shipped to a post office box found high levels of bacterial 
growth (Keim et al., 2013) evidence of tobacco use (Geraghty et al., 2015) and some 
adulteration with bovine milk (Keim et al., 2015); however, the method of collecting samples for 
this study did not reflect how milk is exchanged in commerce‐free peer sharing arrangements, in 
which milk is typically delivered face‐to‐face and ongoing relationships may be established 
(Palmquist & Doehler, 2016; Reyes‐Foster et al., 2015). Furthermore, the study excluded any 
sellers who attempted to screen prospective buyers. Emerging evidence suggests that milk 
recipients participating in commerce‐free peer‐to‐peer milk sharing often employ various forms 
of screening based on their risk perceptions and relationship with the donor (Palmquist & 
Doehler, 2016; Reyes‐Foster et al., 2015). Others have reported increased risks of water dilution 
when donor compensation is deployed (Bloom, 2016). There is currently no research available 
on the pathogen or nutrient composition of human milk exchanged through commerce‐free peer 
sharing. The purpose of this study is to evaluate the bacteria, macronutrients, and antimicrobial 
proteins in human milk shared through a variety of uncompensated channels. 
 
Key messages 
• There is no evidence of differences in the bacteria levels in expressed human milk 
exchanged through commerce‐free models, including non‐profit milk banking and peer 
sharing, compared to milk collected for use within the maternal‐infant dyad. 
• There is no evidence of differences in the macronutrient composition and antimicrobial 
protein content in expressed human milk by modes of commerce‐free exchange. 
Similarly, there is no evidence of water dilution by method of exchange. 
• Evidence‐based public health messages about the risks and benefits of commerce‐free 
human milk exchange are needed. 
 
2 METHODS 
 
This study was approved by the Institutional Review Boards of Elon University and North 
Carolina State University (protocol #12‐054) and North Carolina State University (protocol 
#9581). Individual study participants provided informed consent to release their milk for 
analyses. Samples received through third‐party organizations or community gatekeepers relied 
on the organization's collection and consent processes, and no additional consent was obtained. 
All samples were blinded and assigned an anonymous identification number prior to analyses to 
maintain participant confidentiality and reduce potential researcher bias. 
 
2.1 Participant recruitment 
 
Samples of expressed human milk were solicited via multiple commerce‐free channels used for 
human milk donation between September 2015 and March 2016. The treatment groups for this 
study were as follows: milk expressed by an individual for their own infant (MOM); milk 
expressed by an individual to share with others or expressed milk received through an 
uncompensated exchange with a peer (SHARED); milk from a screened donor that was donated 
to one of three non‐profit milk banks in the HMBANA network (BANKED); and milk that was 
donated to a hybrid milk exchange model that dispenses raw milk from donors who have 
undergone serological screening (SCREENED). Samples from unique donors were obtained for 
each study treatment group by recruiting on social networking websites associated with 
breastfeeding and milk sharing (for MOM and SHARED groups) and by working directly with 
third‐party organizations (WakeMed Mothers' Milk Bank, Raleigh, NC, USA; Mothers' Milk 
Bank Iowa, Coralville, IA, USA; Oklahoma Mothers' Milk Bank, Oklahoma City, OK, USA; and 
Mothers' Milk Alliance, Madison, WI, USA). Although no instructions were provided for sample 
collection so that the study would reflect normal milk expression practices, it is common practice 
for milk bank donors to receive instructions for collecting and storing human milk. To reduce the 
risk for collection bias, we obtained samples that had been expressed prior to study enrolment. 
Individuals who provided milk were asked to give basic information including date of parturition 
and date of sample expression to compute a stage of lactation. Using mean and standard 
deviation values for total protein (1.16 ± 0.25), lactose (7.80 ± 0.88), and total fat (3.22 ± 1.00) 
reported by Wojcik et al. (2009) in a cross‐sectional study of 273 lactating women, the sample 
size necessary to detect a 20% difference in mean values between two independent groups using 
a power of 80% and an alpha of 0.05 was 19, 6, and 39 for protein, lactose, and fat, respectively. 
No adjustment to sample size was made for potential multiple comparisons analysis. Samples 
collected per treatment group were 30 for MOM, BANKED, and SCREENED and 31 for 
SHARED. All samples were received in a frozen state and were transported on ice to the 
laboratory at North Carolina State University where they were thawed, aliquoted, and stored at 
−80 °C until further analysis. Storage duration for each sample was computed using the date at 
the end of study enrolment (March 31, 2016) less the date that the sample was expressed, and the 
stage of lactation was computed using the parturition date less the date the sample was 
expressed. Parturition data were missing for 14/121 samples (11.6%), with the SHARED group 
having the most missing parturition dates (11/31, 35%). 
 
2.2 Bacterial analysis 
 
Human milk samples were thawed and cultured for total aerobic bacteria, coliform, 
and Staphylococcus aureus using Petrifilm plates (3 M Company, St. Paul, MN, USA). Total 
aerobic bacteria and coliform were selected because they are measures of quality used in the 
bovine milk industry (United States Food and Drug Administration, 2015a), and S. aureus was 
selected due to case reports of infections via human milk (Gastelum, Dassey, Mascola, & 
Yasuda, 2005; Kayıran, Can, Kayıran, Ergonul, & Gürakan, 2013). Samples were analysed in 
duplicate using various dilutions with sterile 0.1% peptone water. Additional dilutions were 
used, if needed, to get readings within the ranges stated by the manufacturer. Petrifilm plates 
were incubated at 35 °C per the manufacturer's instructions, and colony‐forming units (CFUs) 
were counted using a light box, magnifier, and hand counter. Petrifilm products are AOAC 
International (Rockville, MD, USA) approved reference methods for use in the dairy industry 
and have been used to analyse bacteria in human milk (Meng et al., 2016; United States Food 
and Drug Administration, 2015a). Forty‐seven per cent (57/121) of the samples exhibited growth 
on the Petrifilm Staph Express plates that did not conform to the manufacturer definition 
of S. aureus, due to the lack of a distinct violet colour. Twenty per cent of these samples (12/57) 
were sent to the North Carolina State University Veterinary School for further analysis by a 
trained researcher in S. aureus identification. Samples were evaluated by gram staining, 
coagulase test, catalase test, and mannitol fermentation. No samples were identified as S. aureus, 
and 11/12 samples were identified as coagulase‐negative staphylococcus. 
 
2.3 Macronutrient analysis 
 
Per cent fat and per cent water were measured using an SMART Trac Rapid Moisture/Fat 
Analyser (CEM Corporation, Matthews, NC, USA), which has previously been validated for use 
with human milk (Fogleman, 2008). The CEM Smart Trac combines NMR techniques and 
microwave drying and has variations less than 3%; therefore, single measurements for fat and 
water content were obtained. Total protein was measured in triplicate using a Bicinchoninic Acid 
(BCA) kit (Pierce Biotechnology, Rockford, IL, USA). The BCA assay uses bovine serum 
albumin as the protein standard and has been shown to have a very high correlation (r = 0.99) 
with Kjeldahl (Keller & Neville, 1986) as the reference method, which was greater than the 
correlation seen with the biuret assay (r = 0.96), the Lowery‐Peterson assay (r = 0.97), and the 
Coomassie Blue assay (r = 0.89), though protein tends to be overestimated with BCA compared 
to Kjeldahl (Keller & Neville, 1986). The average intraassay coefficient of variation (CV) for 
total protein was 3.0%. Lactose was measured using a method modified from Upreti, McKay, 
and Metzger (2006) using high‐performance liquid chromatography (Waters 1525 Binary Pump, 
Waters, Milford, MA, USA) and a refractive index detector (Waters 2414 Refractive Index 
Detector). Lactose was measured in duplicate for 58% of samples with a CV of 4.0%. 
 
2.4 Antimicrobial protein analysis 
 
The activity of lysozyme, an antibacterial enzyme that lyses the cell wall of gram‐positive and 
gram‐negative bacteria (Chipman & Sharon, 1969; Lönnerdal, 2013; Shah, 2000), was measured 
in triplicate based on changes in turbidity to a suspension of Micrococcus lysodeikticus (M3770; 
Sigma‐Aldrich; St. Louis, MO, USA), using methods developed by Shugard (1952) and adapted 
to run in a 96‐well plate (Lee & Yang, 2002). The average CV for lysozyme activity was 9.6%. 
The activity of secretory immunoglobulin A (sIgA), a custom antibody to the pathogens found in 
a mother's environment (Lönnerdal, 2013), was analysed in triplicate using an enzyme‐linked 
immunosorbent assay that binds human milk IgA between Escherichia coli antigens (Michigan 
State University; East Lansing, MI, USA) and antihuman IgA peroxidase antibodies (A0295; 
Sigma‐Aldrich), with purified human IgA from colostrum (I2636; Sigma‐Aldrich) used as a 
standard (Chen & Allen, 2001; Viazis, Farkas, & Allen, 2007). The average CV for sIgA activity 
was 2.6%. 
 
2.5 Statistical analysis 
 
Data for total protein, per cent fat, and per cent water followed a normal distribution, and data for 
lactose, lysozyme activity, sIgA activity, bacteria counts, days postpartum, and storage duration 
followed non‐parametric distributions per evaluation with the Shapiro–Wilk test. Differences 
between treatment groups for numerical data were evaluated using a one‐way ANOVA test for 
normally distributed data and a Kruskal–Wallis test for non‐parametric data. Categorical 
variables were evaluated using a Chi‐Square test. Regression analysis was used to evaluate the 
impact of confounding variables. Data analysis was conducted using SAS Enterprise Edition 9.4 
(SAS Software, Cary, North Carolina). 
 
3 RESULTS 
 
3.1 Bacteria 
 
Fifty‐seven per cent of all samples (69/121) exhibited some bacterial growth, 16.5% of all 
samples (20/121) exhibited coliform growth, and 4.1% of all samples (5/121) 
exhibited S. aureus growth. There was no evidence of differences (p > .05) in the prevalence of 
samples that experienced any growth of aerobic bacteria, coliform, or S. aureus based on method 
of exchange (Table 1). Similarly, the prevalence of samples with limited growth (1.0 log or less), 
low growth (>1.0 to 3.0 log), moderate growth (>3.0 to 5.0 log), and high growth (>5.0 log) did 
not differ between exchange methods for total aerobic bacterial counts or coliform counts 
(Figure 1). Twelve per cent of all samples (15/121) had total aerobic bacteria counts above 5.0 
Log CFUs/mL, which serves as the cut‐off value used by some donor milk bank networks 
regarding eligibility for donation (Bharadva et al., 2014; UKAMB, 2003). Across all samples, 
the median (interquartile range) log CFUs/mL was 2.54 (3.94) for total aerobic bacteria, 0.0 (0.0) 
for coliform count, and 0.0 (0.0) for S. aureus. There was no evidence of differences in the 
distribution (median, IQR) of bacteria levels between exchange methods (Table 2). 
 
 
 
Notes: P-value for Chi-Square test of distribution of total aerobic bacteria count by treatment group = 0.252; P-value 
for Chi-Square test of distribution of Coliform count by treatment group = 0.617. 
Figure 1. Distribution of total aerobic bacteria count and coliform count by method of exchange. 
Notes: p value for Chi‐Square test of distribution of total aerobic bacteria count by treatment 
group = .252; p‐value for Chi‐Square test of distribution of coliform count by treatment 
group = .617. 
 
Table 1. Proportion of human milk samples with any bacterial growth by method of exchange  
BANKED (n = 30) MOM (n = 30) SCREENED (n = 30) SHARED (n = 31) p‐value* 
Total aerobic 18 (60) 18 (60) 16 (53) 17 (55) .9310 
Coliform 8 (27) 3 (10) 6 (20) 3 (10) .2142 
S. aureus 1 (3) 1 (3) 2 (6) 1 (3) .8855 
No growth 12 (40) 12 (40) 14 (47) 14 (45) .9310 
Note. Number of samples per treatment group (% within treatment group); 
* p value for differences in proportion of samples with any growth evaluated with Chi‐Square test. 
 
Table 2. Summary of nutrients, antimicrobial proteins, and bacteria in human milk samples by 
treatment group  
BANKED 
(n = 30) 
MOM  
(n = 30) 
SCREENED 
(n = 30) 
SHARED 
(n = 31) 
p‐value 
Normal data—Mean (stdev)* 
     
Water (%) 88.2 (1.1) 87.5 (1.4) 87.8 (1.2) 87.6 (1.5) .233 
Fat (%) 3.3 (1.1) 3.9 (1.5) 3.7 (1.2) 3.6 (1.3) .326 
Protein (g/dL) 1.5 (0.2) 1.4 (0.3) 1.6 (0.2) 1.5 (0.3) .081 
Non parametric data—Median (IQR)** 
     
Days postpartum*** 147 (136) 183 (214) 99 (111) 101 (180) .501 
Days storage 297 (134) 175 (199) 336 (75) 238 (251) <.001 
Lactose (g/dL) 6.8 (0.6) 6.6 (0.6) 6.5 (0.5) 6.5 (0.7) .085 
sIgA (mg/mL) 0.35 (0.22) 0.45 (0.45) 0.32 (0.22) 0.30 (0.23) .847 
Lysozyme (in 1,000 units/mL) 18 (24) 30 (20) 24 (20) 15 (21) .094 
Total aerobic count (Log10) 3.0 (4.7) 2.9 (3.9) 0.8 (3.9) 1.2 (3.2) .677 
Coliform (Log10) 0 (0.7) 0 (0) 0 (0) 0 (0) .268 
S. aureus (Log10) 0 (0) 0 (0) 0 (0) 0 (0) .905 
* Normally distributed data reported as means (standard deviation) and evaluated using one‐way ANOVA; 
** Non‐parametric data reported as medians (interquartile range) and evaluated using Kruskal–Wallis test; 
stdev = standard deviation; IQR = interquartile range; 
*** Days postpartum data represents n = 30 for BANKED, n = 28 for MOM, n = 30 for SCREENED, and n = 19 for 
SHARED due to missing data on parturition date. 
 
3.2 Nutrients and antimicrobial proteins 
 
No evidence of differences in total protein, fat, or water content was observed by treatment 
group. Mean protein values (95% confidence interval) were 1.5 g/dL (1.4, 1.6) for BANKED, 
1.4 g/dL (1.3, 1.5) for MOM, 1.6 g/dL (1.5, 1.7) for SCREENED, and 1.5 g/dL (1.4, 1.6) for 
SHARED, which was not significantly different (p = .081). Mean fat values (95% confidence 
interval) were 3.3% (2.9, 3.7) for BANKED, 3.9% (3.3, 4.4) for MOM, 3.7% (3.3, 4.2) for 
SCREENED, and 3.6% (3.1, 4.1) for SHARED (p = .326). Mean water values (95% confidence 
interval) were 88.2% (87.7, 88.6) for BANKED, 87.5% (87.0, 88.0) for MOM, 87.8% (87.3, 
88.2) for SCREENED, and 87.6% (87.0, 88.1) for SHARED (p = .233). Similarly, there was no 
observed difference in the distribution of sIgA activity (p = .847), lysozyme activity (p = .094), 
and lactose (p = .085) between treatment groups. Results by treatment group are summarized in 
Table 2. 
 
3.3 Milk attributes 
 
There was no evidence (p = .501) of differences in the distribution of the stage of lactation by 
treatment group (Table 2). There was a significant difference in storage duration, with a median 
(Quartile 1, Quartile 3) storage time of 336 days (300, 375) for SCREENED, 297 days (234, 
368) for BANKED, 238 days (121, 372) for SHARED, and 175 days (87, 286) for MOM 
(p < .001), suggesting that different storage times may have had an impact on study results. 
Regression analysis showed that storage time had a small (R2 < .10), significant inverse 
relationship with two of the dependent variables in this study: sIgA activity (p = .015, R2 = .05) 
and total aerobic bacteria (p = .010, R2 = .06). All other dependent variables were not 
significantly predicted by storage days (p > .05). A total of 29/121 samples (24.0%) had been 
stored longer than 1 year, which is beyond the current storage guidelines (Eglash et al., 2017). 
The proportion of samples stored more than 1 year differed significantly by treatment group 
(26.7% BANKED, 6.7% MOM, 40.0% SCREENED, and 22.6% SHARED; p = .025). 
 
4 DISCUSSION 
 
4.1 Bacteria 
 
The microflora in human milk are diverse and varies significantly between individuals (Bode et 
al., 2014; Hunt et al., 2011). Although historically studied primarily as a source of pathogens, 
the innate microflora in human milk is increasingly viewed as a commensal probiotic; they 
interact with human milk oligosaccharides to seed and feed the infant gut, leading to anti‐
infective and anti‐inflammatory health benefits and contributing to the long‐term development of 
immune and metabolic systems (Castanys‐Munoz, Martin, & Vazquez, 2016; Civardi et 
al., 2013). Culture techniques report that the viable bacteria in human milk mostly resembles 
bacteria found on the skin of the nipple and breast (Sosa & Barness, 1987), which may represent 
a commensal source of bacteria for the infant and not a source of pathogenic contamination. 
Other studies conducted using nonculturing methods suggest that some bacteria are endogenous 
to human milk and do not originate from contact with the skin (Martín et al., 2003; Perez, Doré, 
Leclerc, & Levenez, 2007). A study of preterm infants fed unpasteurized human milk showed 
higher diversity within their gut microbiome than preterm infants fed pasteurized human milk or 
formula, suggesting that bacteria present in raw human milk may contribute to the development 
of the infant microbiome (Cong et al., 2017). 
 
Expressing human milk for feedings that do not occur at the breast/chest may introduce 
additional, potentially pathogenic sources of bacteria through collection, storage, and handling 
practices. Recent findings from the Infant Feeding Practices Study II found that mothers 
expressing milk in the United States predominantly described using storing and handling 
practices within the recommended guidelines (Labiner‐Wolfe & Fein, 2013). In a study of 321 
peer milk‐sharing parents, greater than 75% reported regularly sanitizing pumping equipment 
and washing hands before handling milk (Reyes‐Foster, Carter, & Hinojosa, 2017). Additionally, 
human milk has antimicrobial properties that have been shown to reduce bacteria levels during 
refrigerated storage (Meng et al., 2016; Sosa & Barness, 1987). 
 
Fifty‐seven per cent of samples in this study exhibited some bacterial growth, and 4.1% were 
positive for S. aureus, a coagulase‐positive, virulent strain within the Staphylococcus genus that 
has been implicated in case reports of infections transferred through human milk (Gastelum et 
al., 2005; Kayıran et al., 2013). There was no evidence of differences in the prevalence of total 
aerobic bacteria and S. aureus between methods of exchange, even though donors to the milk 
bank and donors in the SCREENED group reportedly received detailed instructions on safe 
collection and storage practices. Evidence regarding bacteria in expressed human milk intended 
for use outside of the mother/parent–infant dyad is limited. Landers and Updegrove (2010) 
cultured 810 individual samples from 219 approved donors to the Mothers' Milk Bank of Austin 
(Austin, TX, USA) and 303 pools of milk from multiple donors prior to pasteurization and found 
that over 75% of individual and pooled samples exhibited some growth, with coagulase‐
negative Staphylococcus (CoNS) predominating. CoNS species, part of the normal flora of 
human skin and a causative agent in nosocomial infections (Becker, Heilmann, & Peters, 2014), 
have been reported by others (de Almeida Castanho Rozolen, Goulart, & Kopelman, 2006; Law, 
Urias, Lertzman, Robson, & Romance, 1989; Lindemann, Foshaugen, & Lindemann, 2004; 
Thompson, Pickler, Munro, & Shotwell, 1997) as the dominant strain in human milk. A study of 
69 screened donors to the Ulleval University Hospital milk bank (Oslo, Norway) reported CoNS 
in 85% of samples and S. aureus in 13% of samples (Lindemann et al., 2004). In a study of 102 
human milk samples purchased anonymously on the Internet and shipped to a post office box, 
researchers found that over 90% of samples had detectable bacterial growth and 63% of samples 
contained Staphylococcus sp., though the study did not differentiate between CoNS 
and S. aureus (Keim et al., 2013). The high prevalence of observed bacterial growth is likely 
because 64% of samples were received at temperatures above 0 °C. Findings from the study for 
paid and shipped milk may not be generalizable to unpaid models of milk exchange where 
evidence suggests that milk typically exchanged in person (Palmquist & Doehler, 2016; Reyes‐
Foster et al., 2015) likely reducing the time that milk may be exposed to improper storage 
conditions. 
 
There are no agreed upon global standards regarding acceptable prepasteurization bacteria levels 
for donor human milk. The HMBANA does not define a threshold for accepting donations but 
defines standards for dispensing unpasteurized milk as “Only milk from pools with 
<104 CFU/mL of normal skin flora (e.g. coagulase negative Staphylococcus, 
diphtheroids, Staphylococcus epidermis, Streptococcus viridans) is acceptable to dispense raw. 
The presence of any pathogens is unacceptable” (HMBANA, 2015). Several milk banking 
networks globally set raw milk donation limits at less than 5.0 log CFU/mL for milk that will be 
subject to pasteurization (Bharadva et al., 2014; Hartmann et al., 2007; UKAMB, 2003). The 
FDA's “Grade A Pasteurized Milk Ordinance (PMO)” sets the threshold for total bacteria at 5.0 
log CFU/mL for raw bovine milk that is intended for pasteurization, and 4.3 log CFU/mL for 
Grade “A” pasteurized bovine milk (USFDA, 2015a). Additionally, the PMO sets a threshold for 
coliform counts, a marker of sanitation, at 10 to 100 coliforms/mL for Grade “A” pasteurized 
bovine milk (USFDA, 2015a). In this study, 12.4% of samples had total bacteria levels greater 
than 5.0 log CFU/mL, 24.8% of samples had total bacteria levels greater than 4.0 log CFU/mL, 
and 16.5% of the samples were positive for coliform (median 0.0; IQR 0.0), with no evidence of 
differences by method of milk exchange. Thompson et al. (1997) has reported that approximately 
35% of expressed human milk samples had bacterial growth greater 5.0 log CFU/mL, with no 
difference based on whether the breast was washed in advance with water or water and soap. In 
contrast, in the study of human milk purchased anonymously via the Internet and shipped to a 
post office box, 74% of samples exceeded 4.0 log CFU/mL of total bacteria, and coliform growth 
was observed in 44% of the samples (Keim et al., 2013), which may be explained by poor 
temperature control during transportation. 
 
The focus on setting a threshold for acceptable bacteria levels in human milk is not well 
supported by the literature. Law et al. (1989) cultured bacteria in over 10,000 unpasteurized 
human milk feedings from either a mother or an approved donor that were fed to 98 premature 
infants during the first 2 weeks of life. During the study, 100% of infants were exposed to CoNS, 
41% were exposed to S. aureus, and mean feeding bacteria levels for different species ranged 
from 4.7 log CFU/mL to 7.5 log CFU/mL. Law et al. (1989) found no relationship between 
bacteria levels in expressed human milk and feeding intolerance or invasive infection, leading 
the authors to conclude that “results do not support attempts to define a safe upper limit for 
bacterial concentration in raw expressed milk.” Similarly, Schanler et al. (2011) cultured 813 
human milk samples from 161 mothers of preterm infants and found that half of the samples 
were positive for CoNS, 5% were positive for S. aureus, and over 25% of samples had high 
bacteria levels defined as greater than 4.0 log CFU/mL of gram‐positive organisms or greater 
than 3.0 log CFU/ml of gram‐negative organisms. All milk samples were collected in a home 
environment, and milk cultures were not predictive of infectious outcomes in infants. 
 
4.2 Macronutrients and antimicrobial proteins 
 
The present study is the first to examine the macronutrient and antimicrobial protein composition 
of human milk that is given and received through multiple channels of uncompensated human 
milk exchange. The fat and water content of expressed human milk can be manipulated based on 
whether the sample collected represents a full expression of the breast or whether it is primarily 
fore or hind milk (Ballard & Morrow, 2013). We observed no difference in the per cent fat or per 
cent water, suggesting that uncompensated donors are not intentionally giving low‐calorie milk 
or diluting milk with water. Other researchers have reported water dilution in models where 
donors are paid by the ounce (Bloom, 2016). In the present study, there was no evidence of 
differences in total protein, lactose, lysozyme activity, and sIgA activity between methods of 
exchange. There are significant variations in lysozyme and sIgA activity between individuals, 
and concentrations may be influenced based on infant health status and stage of lactation 
(Breakey, Hinde, Valeggia, Sinofsky, & Ellison, 2015; Perrin et al., 2017). This study was not 
powered to detect potential differences in lysozyme or sIgA activity. 
 
4.3 Non‐commercial sharing of expressed human milk 
 
Recipients engaged in peer‐to‐peer milk sharing frequently cite problems establishing or 
maintaining lactation as a primary motivator for seeking milk (Cassidy, 2012; Gribble, 2014; 
Palmquist & Doehler, 2014; Perrin et al., 2014). The only difference in breastfeeding support 
reported by donors and recipients was from paediatricians and spouses, suggesting that an 
important point of intervention is beyond the maternity care process (Palmquist & 
Doehler, 2014). Child health motivators for seeking shared milk were often related to intolerance 
of infant formula and poor weight gain and infrequently related to serious medical conditions for 
the infant (Gribble, 2014; Palmquist & Doehler, 2016; Perrin et al., 2014). Others have reported 
a high incidence of perceived formula feeding intolerance in term infants, with 67% of families 
switching formula brands during the first 6 months of life (Nevo, Rubin, Tamir, Levine, & 
Shaoul, 2007). Facilitating access to a safe supply of donor human milk may be a strategy to 
support families who are experiencing feeding intolerance with term infants. 
 
There is a lack of evidence regarding health outcomes related to peer‐to‐peer milk sharing, 
making it an important area of future research. The evidence of pathogen transmission through 
human milk is predominantly in the medically fragile population (Decousser et al., 2013; 
Gastelum et al., 2005; Gras‐Le Guen et al., 2003; Rettedal et al., 2012; Ryder, Crosby‐Ritchie, 
McDonough, & Hall, 1977; Stiver, Albritton, Clark, Friesen, & White, 1977; Widger, O'Connell, 
& Stack, 2010), though case reports of transmission to term infants also exist, including a recent 
report of HIV transmission in a developed country (Blumental, Ferster, Van den Wijngaert, & 
Lepage, 2014). An infant's health and age are important factors to consider when weighing risks, 
costs, and benefits of available infant feeding options. Studies of milk sharing practices in the 
United States have found that the majority of parents seeking milk through peer‐to‐peer milk 
sharing are doing so for infants who are on average 7 months of age and not medically fragile 
(Palmquist & Doehler, 2014; Palmquist & Doehler, 2016). In a large observational study of 
online peer‐to‐peer milk sharing communities (Perrin et al., 2014), the predominant child‐health‐
related reason cited for seeking human milk was an intolerance to formula, and the average age 
of recipient infants was 6.2 months (M.T. Perrin, unplubished data). These findings support the 
interpretation that milk sharing increases access to human milk for a population of infants that 
may not otherwise have access due to a variety of barriers, including lack of eligibility, cost, 
proximity, and cultural factors. 
 
This study also contributes to a greater understanding of the nutritional and bioactive 
composition of milk that may be received through peer‐to‐peer milk sharing. Others have 
reported that recipient parents are concerned about the quality of maternal diet and how it may 
affect the composition of shared milk (O'Sullivan et al., 2016; Palmquist & Doehler, 2016). 
Findings of the present study provides an evidence base that parents and their health care 
providers may use in understanding the macronutrient and bioactive composition of shared 
human milk. 
 
Peer‐to‐peer human milk sharing has been conceptualized as a public health risk by the FDA, the 
media, and health authorities and organizations in the United States and abroad (Carter & Reyes‐
Foster, 2016; USFDA, 2015b). Unfortunately, in the public health literature, milk sharing has 
been conflated with commercial peer‐to‐peer enterprises and anonymous purchase of milk, 
despite studies indicating that peer‐to‐peer milk sharing does not involve exchange of milk for 
payment or profit and is rarely anonymous (Palmquist & Doehler, 2016; Reyes‐Foster et 
al., 2015; Reyes‐Foster et al., 2017). Thus, the available literature on human milk exchange and 
associated risks of contamination may not be an apt representation of the risk of uncompensated 
peer‐to‐peer milk sharing. 
 
This study was designed to ascertain the risk of bacterial contamination by collecting MOM and 
SHARED milk in real‐world settings, based on the evidence describing milk sharing practices. 
The study also expanded upon peer‐to‐peer milk sharing by incorporating a health care provider‐
facilitated model of milk sharing, in this case, the Mothers' Milk Alliance (Madison, WI, USA). 
Preliminary findings suggest that this kind of facilitated milk sharing holds potential to provide 
an additional pathway of risk mitigation for commerce‐free peer‐to‐peer milk sharing, which 
incorporates serological and behavioural screening of donors along with skilled breastfeeding 
support for donors and recipients; support for informed decision‐making in the use of 
unpasteurized shared milk; education for appropriate milk expression, storage, and handling for 
both donors and recipients; and monitoring of infant health. Future studies are needed to 
compare various models for health care provider‐facilitated milk sharing, along with larger 
population‐based epidemiological assessments of outcomes for infants who have received shared 
milk. 
 
5 LIMITATIONS 
 
This study was powered to detect differences in protein composition of milk and may not have 
detected differences in more variable milk components including fat, lysozyme activity, sIgA 
activity, and bacteria levels; therefore, lack of evidence in difference should be interpreted 
cautiously. There is the risk that study participants changed their hygiene practices during 
participation in this study. To counter the risk for collection bias, only human milk samples that 
had been expressed prior to enrolling in the study were eligible for analysis. Data about stage of 
lactation are incomplete, often because this information may not have been available for milk 
collected by milk sharing recipients. There were significant differences in how long samples had 
been stored by treatment group, which may have influenced some of the nutrients analysed in 
this study. 
 
6 CONCLUSIONS 
 
Human milk exchanged through a variety of uncompensated channels, including to non‐profit 
milk banks where donors are rigorously screened, showed no evidence of differences in 
prevalence or level of total bacteria, coliform, or S. aureus. Although others have used bacteria 
levels in human milk as a proxy for risk, current evidence in the literature does not support using 
them as a valid indicator of safety. Macronutrients and antimicrobial proteins in the exchanged 
human milk samples did not differ significantly from milk expressed for use within the mother–
infant dyad. Moreover, there was no evidence of water dilution in uncompensated models of 
human milk exchange. These findings are contrary to findings of risks in paid models of human 
milk exchange and fill an important gap in the scientific literature for health care providers and 
families seeking evidence regarding risks and benefits of peer‐to‐peer milk sharing. 
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